Sign In
Buy GH
$130.83
+2.00 (+1.55%)
At Close: Jun 23, 2026
Living Longer Is Big Business. These Stocks Will Benefit.
02:14pm, Thursday, 18'th Jun 2026
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.
Gamehost Receives Final Court Order Authorizing Sale to Pure Casino Entertainment
09:00am, Monday, 15'th Jun 2026
Not intended for distribution to U.S. newswire services or for dissemination in the U.S. Red Deer, Alberta--(Newsfile Corp. - June 15, 2026) - Gamehost Inc. (TSX: GH) ("Gamehost") announced that the
Gamehost Shareholders Approve Sale to Pure Casino Entertainment
01:25pm, Friday, 12'th Jun 2026
Red Deer, Alberta--(Newsfile Corp. - June 12, 2026) - Gamehost Inc. (TSX: GH) ("Gamehost") announced that its shareholders (the "Gamehost Shareholders") have approved its previously announced trans
Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim's HERNEXEOS®
08:05am, Thursday, 11'th Jun 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360�
Here's Why This Colon Cancer Testing Biotech Is A Mutual Fund Favorite
12:10pm, Thursday, 04'th Jun 2026
This biotech has a one-of-a-kind colon cancer blood test. Shares broke out of a base on recent news.
Pre-Market Stock Futures: Futures are trading lower on Tuesday, but the technology tsunami continued on Monday, as all major indices dipped into the red early on news that Iran was halting the peace n
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 38 abstracts,
PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 38 abstrac
Guardant Health Is Poised To Break Out At The Open — Here's Why It Surged
09:11am, Wednesday, 27'th May 2026
Guardant Health stock spiked Wednesday after the American Cancer Society recommended its blood test as a screening tool for colon cancer.
American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
08:00am, Wednesday, 27'th May 2026
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield⢠blood test is now included in updated Ameri
American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
07:47am, Wednesday, 27'th May 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield™ blood test is now included in updated American C
Guardant Health Secures FDA Approval For Expanded Liquid Biopsy Test
12:07pm, Wednesday, 20'th May 2026
The U.S. Food and Drug Administration (FDA) on Wednesday approved Guardant Health Inc.'s (NASDAQ:GH) Guardant360 Liquid CDx test, expanding the company's blood-based comprehensive genomic profiling ca
Guardant Health Leaps On A Major Win In Cancer Detection; Will Shares Break Out?
10:57am, Wednesday, 20'th May 2026
The Food and Drug Administration approved Guardant Health's newest blood cancer test Wednesday, and the stock leaped to a three-month high.
FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint
09:00am, Wednesday, 20'th May 2026
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardan
FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint
08:05am, Wednesday, 20'th May 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360�
